Advertisement
Loading...

Novozymes A/S

NVZMFā€¢PNK
Basic Materials
Chemicals - Specialty
$61.25
$-0.58(-0.94%)
U.S. Market opens in 0h 31m

Novozymes A/S (NVZMF) Stock Overview

Explore Novozymes A/Sā€™s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap28.6B
P/E Ratio10.28
EPS (TTM)$1.51
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 Month$61.28
3 Months$69.94
1 Year Target$72.37

NVZMF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novozymes A/S (NVZMF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $72.37.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.28 and a market capitalization of 28.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.94%
5-Day Change
3.17%
1-Month Change
4.81%
3-Month Change
-4.49%
6-Month Change
-5.91%
Year-to-Date (YTD) Change
-1.95%
1-Year Change
-8.42%
3-Year Change
18.20%
5-Year Change
-12.44%
All-Time (Max) Change
26764.04%

Contact Information

https://www.novozymes.com
45 44 46 00 00
Krogshoejvej 36, Bagsvaerd, NaN, 2880

Company Facts

10,582 Employees
IPO DateOct 15, 2010
CountryDK
Actively Trading

Frequently Asked Questions